https://www.ncbi.nlm.nih.gov/gene/146212
- Preferred Names
- BTB/POZ domain-containing protein KCTD19
- Names
- potassium channel tetramerisation domain containing 19
- testicular tissue protein Li 101
-
NM_001100915.3 → NP_001094385.1 BTB/POZ domain-containing protein KCTD19
See identical proteins and their annotated locations for NP_001094385.1
- Conserved Domains (1) summary
-
- cl02518
Location:18 → 72
- BTB; BTB/POZ domain.The BTB (for BR-C, ttk and bab) or POZ (for Pox virus and Zinc
finger) domain is present near the N-terminus of a fraction of zinc
finger (pfam00096) proteins and in proteins that contain the pfam01344
motif such as Kelch and a family of pox virus proteins. The BTB/POZ
domain mediates homomeric dimerisation and in some instances heteromeric
dimerisation. The structure of the dimerized PLZF BTB/POZ domain has
been solved and consists of a tightly intertwined homodimer. The central
scaffolding of the protein is made up of a cluster of alpha-helices
flanked by short beta-sheets at both the top and bottom of the molecule.
POZ domains from several zinc finger proteins have been shown to
mediate transcriptional repression and to interact with components of
histone deacetylase co-repressor complexes including N-CoR and SMRT. The
POZ or BTB domain is also known as BR-C/Ttk or ZiN.
CDS 1..926
/gene="KCTD19"
/coded_by="NM_001100915.3:35..2815"
/db_xref="CCDS:CCDS42179.1"
/db_xref="GeneID:146212"
/db_xref="HGNC:HGNC:24753"
ORIGIN
1 meesgmahes aedlfhfnvg gwHfsvprsk lsqfpdsllw keasaltsse sqrlfidrdg
61 stfrHvHyyl ytsklsfssc aelnllyeqa lglqlmpllq tldnlkegkh hlrvrpadlp
121 vaeraslnyw rtwkciskps efpikspaft glhdkaplgl mdtplldtee evhycflpld
181 lvakypslvt ednllwlaet valiececse frfivnflrs qkillpdnfs nidvleaeve
241 ileipaltea vrwyrmnmgg cspttcspls pgkgartasl esvkplytma lgllvkypds
301 algqlriest ldgsrlyitg ngvlfqhvkn wlgtcrlplt etisevyelc afldkrdity
361 epikvalkth leprtlapmd vlnewtaeit vyspqqiikv yvgsHwyatt lqtllkypel
421 lsnpqrvywi tygqtlliHg dgqmfrHiln flrlgklflp sefkewplfC qeveeyHips
481 lsealaqCea ykswtqekes eneeafsirr lhvvtegpgs lvefsrdtke ttaympvdfe
541 dcsdrtpwnk akgnlvrsnq mdeaeqytrp iqvslcrnak ragnpstysh crglctnpgh
601 wgshpesppk kkcttinltq ksetkdppat pmqklislvr ewdmvnckqw efqpltatrs
661 spleeatlql plgseaasqp stsaawkahs tasekdpgpq agagagakdk gpeptfkpyl
721 ppkragtlkd wskqrtkere spapeqplpe asevdslgvi lkvthppvvg sdgfcmffed
781 siiyttemdn lrhttptasp qpqevtflsf slsweemfya qkchcfladi imdsirqkdp
841 kaitakvvsl anrlwtlhis pkqfvvdlla itgfkddrht qerlyswvel tlpfarkygr
901 cmdlliqrgl srsvsysilg kylqed
//
-
Novel genetic causes for cerebral visual impairment.
Bosch DG, et al. Eur J Hum Genet, 2016 May. PMID 26350515, Free PMC ArticleAbstract
Cerebral visual
impairment (CVI) is a major cause of low vision in children due to
impairment in projection and/or interpretation of the visual input in
the brain. Although acquired causes for CVI are well known, genetic
causes underlying CVI are largely unidentified. DNAs of 25 patients with
CVI and intellectual disability, but without acquired (eg, perinatal)
damage, were investigated by whole-exome sequencing. The data were
analyzed for de novo, autosomal-recessive, and X-linked variants, and
subsequently classified into known, candidate, or unlikely to be
associated with CVI. This classification was based on the Online
Mendelian Inheritance in Man database, literature reports, variant
characteristics, and functional relevance of the gene. After
classification, variants in four genes known to be associated with CVI
(AHDC1, NGLY1, NR2F1, PGAP1) in 5 patients (20%) were identified,
establishing a conclusive genetic diagnosis for CVI. In addition, in 11
patients (44%) with CVI, variants in one or more candidate genes were
identified (ACP6, AMOT, ARHGEF10L, ATP6V1A, DCAF6, DLG4, GABRB2, GRIN1,
GRIN2B, KCNQ3, KCTD19, RERE, SLC1A1, SLC25A16, SLC35A2, SOX5, UFSP2,
UHMK1, ZFP30). Our findings show that diverse genetic causes underlie
CVI, some of which will provide insight into the biology underlying this
disease process.
-
A Genome-Wide Screen for Machinery Involved in Downregulation of MHC Class I by HIV-1 Nef.
Choma MK, et al. PLoS One, 2015. PMID 26466362, Free PMC ArticleAbstract
The HIV-1-encoded
protein, Nef, plays a key role in the development of AIDS. One of Nef's
functions is to keep MHC class I off the surface of infected cells, a
process that requires the host proteins clathrin and AP-1. To identify
other proteins involved in this pathway, we carried out a genome-wide
siRNA library screen on HeLa cells co-expressing HLA-A2 and an inducible
form of Nef. Out of 21,121 siRNA pools, 100 were selected for further
analysis, based on their ability to either inhibit or enhance
downregulation of MHC-I by Nef. When cells were treated with the same
siRNA pools as those used in the screen, 79% produced a similar
phenotype. However, when the cells were treated with different siRNA
reagents targeting the same genes, only 16% produced a similar
phenotype. This indicates that most of the hits found in the original
screen are likely to have been off-target, an important concern that is
often not taken into account in siRNA screening studies. Nevertheless,
we identified novel host factors involved in Nef-induced downregulation
of MHC-I, including four genes, MIIP, CAMSAP3, SLC6A3, and KCTD19, where
multiple reagents produced a strong inhibitory effect on Nef activity.
Other hits slightly below our very high stringency cutoff point may also
deserve further study. Thus, our dataset is a valuable resource for
scientists investigating the pathogenesis of HIV.
-
A proteome-scale map of the human interactome network.
Rolland T, et al. Cell, 2014 Nov 20. PMID 25416956, Free PMC Article
-
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Ota T, et al. Nat Genet, 2004 Jan. PMID 14702039
-
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, et al. Proc Natl Acad Sci U S A, 2002 Dec 24. PMID 12477932, Free PMC Article
Inga kommentarer:
Skicka en kommentar